Provided by Tiger Trade Technology Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.9545
+0.05225.79%
Post-market: 0.97820.0237+2.48%19:58 EDT
Volume:852.12K
Turnover:807.21K
Market Cap:121.30M
PE:-2.14
High:0.9782
Open:0.9200
Low:0.8900
Close:0.9023
52wk High:4.31
52wk Low:0.6200
Shares:127.08M
Float Shares:63.02M
Volume Ratio:1.63
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4464
EPS(LYR):-0.4673
ROE:-36.21%
ROA:-20.83%
PB:0.93
PE(LYR):-2.04

Loading ...

Nautilus Biotechnology Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Nautilus Biotechnology Posts First Revenue, Q2 Net Loss Narrows

Reuters
·
Jul 28

Nautilus Biotechnology Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 Operating Expenses USD 15.938 Million

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 EPS USD -0.11

THOMSON REUTERS
·
Jul 28

Nautilus Biotechnology Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $190.000K

Benzinga Earnings
·
Jul 28

Nautilus Biotechnology Inc Expected to Post a Loss of 13 Cents a Share - Earnings Preview

Reuters
·
Jul 24

Nautilus Biotechnology And 2 Promising Penny Stocks To Consider

Simply Wall St.
·
Jul 11

Nautilus Biotechnology to Report Q2 Results, Host Conference Call

Reuters
·
Jul 08

Nautilus Biotechnology shareholders elect Class II directors Mallick, Nazem at annual meeting

Reuters
·
Jun 19

AH Equity Partners Bio II disposes of 5,000,000 Nautilus Biotechnology shares worth $11,750,000

Reuters
·
Jun 05

Guggenheim Remains a Buy on Nautilus Biotechnolgy (NAUT)

TIPRANKS
·
Apr 29

Nautilus Biotechnology announces annual shareholder meeting webcast

Reuters
·
Apr 29

Nautilus Biotechnology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 28

BRIEF-Nautilus Biotechnology Q1 EPS USD -0.12

Reuters
·
Apr 28

Nautilus Biotechnology Q1 Operating Expenses USD 16.124 Million

THOMSON REUTERS
·
Apr 28

Press Release: Nautilus Biotechnology Reports First Quarter 2026 Financial Results

Dow Jones
·
Apr 28

Nautilus Biotechnology Q1 FY26 net loss narrows to $14.7 million; operating expenses fall 14% to $16.1 million

Reuters
·
Apr 28

Nautilus Biotechnology Q1 EPS $(0.12) Beats $(0.17) Estimate

Benzinga Earnings
·
Apr 28

Nautilus Biotechnology Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
Apr 24